Pacific Biometrics Names New Senior VP of Operations

SEATTLE--(BUSINESS WIRE)--May 31, 2005--Pacific Biometrics Inc. (OTCBB: PBME, "PBI") has appointed Michael Murphy, Ph.D., as the new Senior Vice President of Operations. Murphy will play a key role in managing all aspects of the PBI service business including lab operations, client and information services, and quality assurance/control. Murphy will also work directly with the rest of the senior management team to help grow the service business.

Murphy brings to PBI more than 15 years' experience in laboratory operations. Murphy joins PBI from Laboratory Corporation of America (LabCorp(R)), where he served as Technical Director responsible for three of its West Division labs (Northwest, Reno, and Salt Lake regions). In this role, he provided technical operation leadership for all areas of operation, as well as directed the operational re-design of the labs for cost reductions and new technology introduction. Murphy has held several leadership positions at research centers, including Laboratory Director at Eastern Maine Medical Center and Director of Professional Services at CompuLab Corporation. Murphy earned a BS in Natural Sciences from Xavier University in Cincinnati, Ohio and a doctorate in pathology and physiological chemistry from The Ohio State University.

“We are pleased to have Mike Murphy join PBI as we look to grow market share for our lab services business and penetrate the mid-sized trial market”

"We are pleased to have Mike Murphy join PBI as we look to grow market share for our lab services business and penetrate the mid-sized trial market," said Ron Helm, CEO of PBI. "His experience building sales, marketing and service teams, depth of education in the life sciences field and successes as an operational leader will make him an invaluable addition to our senior management team."

About Pacific Biometrics, Inc. (PBI)

Established in 1989, PBI provides specialized central laboratory and contract research services to support pharmaceutical and diagnostic manufacturers conducting human clinical trial research. The company provides expert services in the areas of cardiovascular disease, diabetes, osteoporosis, arthritis, and nutrition. The PBI laboratory is accredited by the College of American Pathologists and through its non-profit affiliate Pacific Biometrics Research Foundation is one of only three U.S.-based laboratories approved and accredited by the Center for Disease Control (CDC) as a Cholesterol Reference Laboratory. PBI's clients include many of the world's largest pharmaceutical, biotech and diagnostic companies.

Pacific Biometrics also owns several patented and patent-pending technologies, including monitoring devices for glucose and changes in bone turnover, an advanced, proprietary, isothermal DNA amplification technology, and a gene-based cell viability technology to distinguish live from dead cells in a broad range of diagnostic applications.

For more information about Pacific Biometrics, visit the company's web site at www.pacbio.com or contact Ronald Helm, Chairman / CEO at 206-298-0068.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release includes forward-looking statements including to but not limited to our strategic planning and business development plans, our future growth, and the viability and acceptance of our products and services in the market. These forward-looking statements are subject to a number of risks and uncertainties that may cause actual results to differ materially from those described in the forward-looking statements. These risks include, but are not limited to, our ability to bid on and win laboratory services contracts, the success of our marketing and business development efforts, competition in the industry, and our ability to manage growth and our investments in our infrastructure, as well as the risks and other factors set forth in our periodic filings with the U.S. Securities and Exchange Commission (including our Form 10-KSB, Forms 10-QSB and our Form SB-2 registration statements).